Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 6 | 2015 | 591 | 0.940 |
Why?
|
| Glutamic Acid | 3 | 2015 | 131 | 0.900 |
Why?
|
| Neurons | 9 | 2025 | 1246 | 0.760 |
Why?
|
| Synapses | 4 | 2008 | 184 | 0.480 |
Why?
|
| Cyclic AMP | 1 | 2015 | 135 | 0.440 |
Why?
|
| Synaptic Transmission | 2 | 2014 | 156 | 0.440 |
Why?
|
| Presynaptic Terminals | 2 | 2014 | 54 | 0.430 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2014 | 10 | 0.430 |
Why?
|
| Cerebellum | 2 | 2005 | 78 | 0.420 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2005 | 81 | 0.410 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 74 | 0.410 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2005 | 81 | 0.370 |
Why?
|
| Receptors, GABA | 2 | 2001 | 28 | 0.350 |
Why?
|
| Receptors, GABA-A | 4 | 2003 | 65 | 0.320 |
Why?
|
| Calcium Channels | 1 | 2008 | 74 | 0.270 |
Why?
|
| Neuronal Plasticity | 1 | 2008 | 126 | 0.250 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2025 | 19 | 0.230 |
Why?
|
| Prosencephalon | 1 | 2025 | 34 | 0.230 |
Why?
|
| Egtazic Acid | 1 | 2005 | 14 | 0.230 |
Why?
|
| Type C Phospholipases | 1 | 2005 | 24 | 0.230 |
Why?
|
| Purkinje Cells | 1 | 2005 | 19 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 1804 | 0.230 |
Why?
|
| Phenylurea Compounds | 2 | 2015 | 18 | 0.220 |
Why?
|
| Cells, Cultured | 7 | 2015 | 1617 | 0.220 |
Why?
|
| Caspase 3 | 1 | 2025 | 226 | 0.220 |
Why?
|
| Signal Transduction | 3 | 2015 | 2111 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2025 | 255 | 0.200 |
Why?
|
| Peptide Fragments | 1 | 2025 | 301 | 0.200 |
Why?
|
| Animals | 13 | 2025 | 16695 | 0.200 |
Why?
|
| Receptors, GABA-B | 1 | 2001 | 11 | 0.180 |
Why?
|
| Mice | 8 | 2025 | 6490 | 0.180 |
Why?
|
| Neural Inhibition | 3 | 2008 | 48 | 0.170 |
Why?
|
| Genetic Vectors | 1 | 2001 | 165 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 187 | 0.170 |
Why?
|
| Esophageal Neoplasms | 1 | 2022 | 137 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 4 | 2008 | 228 | 0.160 |
Why?
|
| Phosphorylation | 2 | 2025 | 973 | 0.140 |
Why?
|
| Gene Expression | 1 | 2001 | 692 | 0.140 |
Why?
|
| Synapsins | 2 | 2015 | 7 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 144 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2018 | 170 | 0.130 |
Why?
|
| Cholinergic Agents | 1 | 2015 | 8 | 0.120 |
Why?
|
| Isoxazoles | 1 | 2015 | 14 | 0.120 |
Why?
|
| Intracellular Space | 1 | 2015 | 37 | 0.120 |
Why?
|
| Choline | 1 | 2015 | 61 | 0.110 |
Why?
|
| Receptor, trkB | 2 | 2005 | 19 | 0.110 |
Why?
|
| Evoked Potentials | 2 | 2005 | 90 | 0.100 |
Why?
|
| Benzamides | 1 | 2014 | 78 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2014 | 1010 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2014 | 462 | 0.100 |
Why?
|
| Calcium | 1 | 2015 | 487 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2005 | 928 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1066 | 0.080 |
Why?
|
| Synaptic Vesicles | 1 | 2008 | 31 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2001 | 1737 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2005 | 350 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2008 | 139 | 0.060 |
Why?
|
| Median Eminence | 1 | 2005 | 10 | 0.060 |
Why?
|
| Neocortex | 1 | 2005 | 27 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 1112 | 0.060 |
Why?
|
| Rats | 3 | 2001 | 3701 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 457 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2005 | 53 | 0.060 |
Why?
|
| Electric Stimulation | 1 | 2005 | 198 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 189 | 0.050 |
Why?
|
| Esophagectomy | 1 | 2022 | 8 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2022 | 81 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2022 | 73 | 0.050 |
Why?
|
| Ruthenium Red | 1 | 2001 | 4 | 0.050 |
Why?
|
| Humans | 4 | 2022 | 42163 | 0.050 |
Why?
|
| Picrotoxin | 1 | 2001 | 14 | 0.050 |
Why?
|
| Bicuculline | 1 | 2001 | 18 | 0.050 |
Why?
|
| Cell Movement | 1 | 2005 | 640 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2001 | 59 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 1139 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2001 | 21 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2001 | 62 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2001 | 45 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 658 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2001 | 97 | 0.040 |
Why?
|
| Forecasting | 1 | 2001 | 136 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2001 | 93 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 148 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2001 | 93 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2001 | 195 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 293 | 0.040 |
Why?
|
| Cell Death | 1 | 2001 | 277 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2000 | 39 | 0.040 |
Why?
|
| Action Potentials | 1 | 2001 | 246 | 0.040 |
Why?
|
| Male | 2 | 2018 | 22779 | 0.040 |
Why?
|
| Female | 2 | 2018 | 24018 | 0.030 |
Why?
|
| Amygdala | 1 | 2018 | 125 | 0.030 |
Why?
|
| Apoptosis | 1 | 2025 | 1541 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2018 | 369 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 410 | 0.030 |
Why?
|
| Anxiety | 1 | 2018 | 847 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 1452 | 0.020 |
Why?
|
| Vesicle-Associated Membrane Protein 2 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2008 | 33 | 0.020 |
Why?
|
| Pyridinium Compounds | 1 | 2008 | 27 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2008 | 80 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 207 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 526 | 0.020 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2000 | 7 | 0.010 |
Why?
|
| Staurosporine | 1 | 2000 | 38 | 0.010 |
Why?
|
| Naphthalenes | 1 | 2000 | 38 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2000 | 151 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2000 | 124 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2000 | 884 | 0.010 |
Why?
|
| Time Factors | 1 | 2000 | 1848 | 0.010 |
Why?
|